Fenugreek (Trigonella foenum graecum L.) is a legume mainly cultured in the Middle East and in Asia. Fractions of fenugreek have different therapeutic properties, for instance antidiabetic, cholesterol-lowering, antioxidant and anti-inflammatory effects(Reference Madar and Stark1). The seed is interesting as a dietary ingredient in human and animal nutrition due to some remarkable bioactive properties. Fenugreek seeds contain a variety of constituents. Those which are functionally interesting are mainly polysaccharides and flavonoids. They contain 32 % insoluble and 13·3 % soluble fibre, and have high concentrations of galactose and mannose(Reference Roberts2). The galactomannan content of fenugreek varies depending on growth conditions and genotype and can be 12·8–21·5 %(Reference Thomas, Bandara and Lee3). The hypoglycaemic and hypocholesterolaemic effects seem to be mainly linked with the specific composition and biological activity of carbohydrates and the high saponin content(Reference Madar and Stark1, Reference Boban, Nambisan and Sudhakaran4). There is increasing evidence that fenugreek can affect immunological variables in humans and animals. Isolated galactomannans from fenugreek increased the phagocytic rate of peritoneal macrophages in rats(Reference Ramesh, Yamaki and Tsushida5). The galactomannans used in the same study resulted in an activation of human lymphoma cells, increasing the secretion of IgM. The alkaline-extracted polysaccharide fraction was more effective to stimulate the phagocytic activity than the aqueous extract. In mice, the use of an aqueous fenugreek seed extract at 50, 100 and 250 mg/kg body weight had a dose-dependent effect on different immune parameters(Reference Bin-Hafeez, Haque and Parvez6). In obese rats, fenugreek-supplemented diets reduced liver weight and circulating levels of TNF-α(Reference Raju and Bird7). In a study with cyclophosphamide-treated rats, fenugreek alleviated leucopaenia, and increased weights and cellularity of lymphoid organs. Serum γ-globulin levels and delayed type of hypersensitivity response were higher in treated rats compared with the control group(Reference Ramadan, El-Beih and Abd El-Kareem8).
Recently, it has been shown that fenugreek addition to bacterial cultures from porcine colonic digesta resulted in a significant amount of acetate, propionate and butyrate formation(Reference Lin, Gong and Wang9). Besides their potential as a microbial substrate, galactomannans from fenugreek can effectively interfere with ganglioside GM1-binding sites of cholera toxin and of human and porcine Escherichia coli heat-labile enterotoxin(Reference Becker, Widjaja-Greefkes and van Wikselaar10). This would offer perspectives for interventional nutrition with the potential of preventing bacterial enterotoxin-induced diarrhoea, especially in the young piglet after weaning.
Up to now, no feeding studies have been published on fenugreek in pigs to our knowledge. The seed might be interesting due to its potential impact on the intestinal microbiota and its immune-modulating effects. The present study hypothesised that these effects might affect the digestive physiology of piglets after weaning. We have demonstrated an impact of a diet supplemented with 1·5 g fenugreek seed/kg on the intestinal microbiota in piglets and on selected traits of the immune system.
Experimental methods
Animals and housing
The experiment was approved according to the rules of the German Animal Welfare Law by the Landesamt für Gesundheit und Soziales, Berlin (registration no. 0267/08). A total of twenty-one male castrated piglets (Duroc × Piétrain), weaned at day 21 with an average body weight of 8·26 (sd0·83) kg, were used in the study. The piglets were randomly allocated into the control group with eleven animals and the fenugreek group with ten animals. The animals were kept pairwise over a period of 4 weeks in flat-deck pens on a plastic slatted floor. The room temperature was 28°C initially and was decreased to 25°C within 10 d. Humidity was kept constant at approximately 65 %. A light programme ensured a 16 h light and 8 h dark phase. Daily feed intake was recorded for each pen and the individual body weights of the animals were recorded weekly. Health status was examined daily for clinical signs of disease, in particular the presence of diarrhoea.
Feed and feed analysis
The animals had free access to water. The daily feed allowance was adjusted according to the calculated energy requirements. The diets were offered as mash and met the requirements for piglets at this age(11, 12) (Table 1). The proximate nutrient concentrations of the feed were determined by Weende analysis(Reference Naumann and Bassler13). Ca, P and Na were determined after ashing using atomic absorption spectrometry. P was measured by the ammonium vanadate/molybdate method. Chromium oxide was included as an indigestible marker for the measurement of nutrient digestibility (data not reported). The galactomannan concentration of the fenugreek seed was 28 % and the concentration of apigenin-7-glycoside was 0·672 % (analysis by Belan Laboranalytik).
* Vitamin and mineral premix (Spezialfutter Neuruppin) containing per kg: 600 000 IU vitamin A (36 000 μg retinol), 120 000 IU vitamin D3 (3000 μg cholecalciferol), 8000 mg vitamin E, 300 mg vitamin K, 250 mg thiamin, 250 mg riboflavin, 2000 μg cobalamine, 2500 mg nicotinic acid, 25 000 μg biotin, 100 mg folic acid, 1000 mg pantothenic acid, 133 g Na (NaCl), 55 g Mg (magnesium oxide), 5000 mg Fe (Fe(II) carbonate), 1000 mg Cu (copper(II) sulphate, pentahydrate), 5000 mg Zn (zinc oxide), 6000 mg Mn (manganese(II) oxide), 45 mg I (calcium iodate), 35 mg Se (sodium selenite).
† Fenugreek seed was added at 1·5 g/kg diet only for the fenugreek group.
Sampling
At days 28 and 29 of the experiment, blood samples were taken from the anaesthetised animal by cardiac puncture by a blood collecting system (S-Monovette®; Sarstedt). The piglets were killed 2 h after their last meal. They were anaesthetised with ketamine hydrochloride (Ursotamin®, 10 %; Serumwerk Bernburg AG) and azaperone (Stresnil®; Jansen-Cilag) (0·2 ml/0·1 ml per kg body mass), and killed with tetracaine hydrochloride, mebezonium iodide and embutramide (T61®; Intervet). Subsequently, the stomach, distal jejunum, ileum and the caecum and colon contents were removed.
Bacterial cell concentrations in the stomach and gastrointestinal segments
Quantification of bifidobacteria, enterobacteria, lactobacilli (L. amylovorus, L. reuteri and L. johnsonii), the Escherichia/Hafnia/Shigella group, clostridium clusters I and XIVa and streptococci in the jejunal and caecal digesta was accomplished by quantitative PCR. Total nucleic acids were extracted by shearing 1 g sample with a 4 m-guanidinisothiocyanate solution and 3 g of glass beads in a bead beater. After phenol–chloroform extraction, the nucleic acids were collected by isopropanol precipitation and purified with commercial spin columns (Macherey-Nagel). DNA content was determined by fluorometric quantification (NanoDrop ND 3300; Fisher Scientific) using the Hoechst 33 258 dye and calf thymus DNA as a reference. Cell numbers for the Escherichia group (Escherichia spp., Hafnia spp. and Shigella spp.) were detected with a Taqman assay(Reference Lyons, Griffen and Leys14). Lactobacilli(Reference Walter, Hertel and Tannock15), bifidobacteria(Reference Rinttilä, Kassinen and Malinen16), clostridium clusters I and IV(Reference Song, Liu and Finegold17) as well as L. reuteri, L. johnsonii and L. amylovorus (Reference Walter, Tannock and Tilsala-Timisjarvi18) were detected using the stated published primer sequences. Streptococci were detected using the following primer combination, which was validated in the institute: Str1-f 5′-CCG CAT AAC AGC TTT TGA CA-3′ and Str1-r 5′-GGT AGG CCG TTA CCC TAC CT-3′. All primers were purchased from MWG Biotech. A Stratagene MX3000p (Stratagene) was used for PCR amplification and fluorescent data collection. The mastermix consisted of 12·5 μl Brilliant SYBR Green QPCR Mastermix (Stratagene) or 12·5 μl HotStartTaq Mastermix (Qiagen) for Taqman assays, 0·5 μl of each primer (10 μm), 0·75 μl 5-carboxy-X-rhodamine (ROX) reference dye (1:500 diluted) and 10·75 μl water. Before PCR amplification, 1 μl sample was added. All amplification programmes included an initial denaturation step at 95°C for 15 min to activate the polymerase. All PCR programmes featured an annealing time of 30 s, and a 30 s extension at 72°C. The annealing temperature was 50°C for Escherichia cell numbers, 55°C for lactobacilli, streptococci, both clostridium clusters as well as L. reuteri, and 58°C for bifidobacteria, L. johnsonii and L. amylovorus. As a quantification procedure(Reference Vahjen, Taras and Simon19), a series of autoclaved pig faecal samples were spiked with different bacterial species and known cell numbers (109–103 cells/g wet weight). After extraction and purification, these extracts were used as PCR calibration samples, and the results were expressed as cell numbers/g sample wet weight.
pH and bacterial metabolites in the digesta
pH was measured in the digesta by a pH electrode connected to a pH meter (seven Multi; Mettler Toledo). d- and l-lactate concentrations in the digesta of intestinal contents were determined by a HPLC system (Agilent 1100; Agilent Technologies). For the analysis of lactate, 0·5 g digesta were mixed at a ratio of 1:1 with ice-cold 0·5 m-copper sulphate solution. After centrifugation, the supernatant was mixed with 50 μl of 85 mm-K4[Fe(CN)6].3H2O (Carrez I), and incubated on ice for 5 min. Then, 50 μl of 250 mm-ZnSO4.7H2O (Carrez II) were added and the samples were again incubated on ice for 5 min. The supernatant was filtered through cellulose acetate syringe filters and separated on a Phenomenex Chirex 3126 (d)-penicillamine (150 × 4·6 mm; Phenomenex Company) fitted with a Phenomenex pre-column (C18 4·0 mm × 2·0 mm inner diameter; Phenomenex Company). For the analysis of SCFA, 300 mg digesta were diluted in distilled water, homogenised and centrifuged (Heraeus Instruments) at 13 000 rpm for 15 min. Hexanic acid was used as an internal standard (0·5 mmol/l). The sample (1·0 μl) was analysed by a gas chromatograph (Model 19095N-123; Agilent Technologies), fitted with a HP-INNOWax column A (length 30 m, internal diameter 530 μm, with a film thickness of 1·0 μm). The initial temperatures of the oven, injector and FID detector were 70, 230 and 250°C. Hydrogen gas was used as a carrier gas (gas generator: Parker ChromGas; Parker Hannifin Corporation) at a flow rate of 30 ml/min.
Blood count
Blood count was carried out with EDTA blood (Laboklin).
Flow cytometry for immune cell phenotyping
Peripheral blood mononuclear cells were isolated by density gradient centrifugation using Ficoll. Flow cytometry was carried out as described previously(Reference Schierack, Filter and Scharek20). Staining of purified immune cell preparations for CD4 and CD8α was performed with labelled primary antibodies in a one-step incubation. All other immune cell antigens were detected using unlabelled primary antibodies followed by washing and incubation with a fluorescence-labelled secondary antibody (see below). Cells were assayed by flow cytometry using a FACSCalibur flow cytometer equipped with a 488 nm argon laser (FACS Calibur; Becton Dickinson).
Labelled primary antibodies used for flow cytometry are as follows: mouse anti-porcine CD4 clone 74-12-4, conjugated to fluorescein isothiocyanate; mouse anti-porcine CD8α clone PT8, conjugated to R-phycoerythrin. Unlabelled primary antibodies used for flow cytometry are as follows: mouse anti-porcine CD2, clone MSA4 (kind gift from Professor A. Saalmüller, University of Veterinary Medicine Vienna, Vienna, Austria); mouse anti-porcine CD5, clone b53b7 (gift from Professor A. Saalmüller); mouse anti-porcine CD8β clone PG164A (VMRD); mouse anti-porcine CD14, clone MIL2 (Serotec); mouse anti-porcine CD21, clone BB6-11C9.6 (Southern Biotech); mouse anti-porcine CD25, clone K231.3B2 (Acris); mouse anti-porcine TcR1-N4 (δ-chain), clone PGBL22A (VMRD); mouse anti-porcine MHCII, clone MSA3 (VMRD); mouse anti-porcine CD45 RC, clone 3a56 (gift from Professor A. Saalmüller); mouse anti-porcine CD172a, clone 74-22-15A (BD Pharmingen). Secondary antibodies are as follows: goat anti-mouse IgG, conjugated to fluorescein isothiocyanate or to phycoerythrin (PE) (Southern Biotech).
Phagocytosis assay
Phagocytosis of opsonised fluorescein isothiocyanate-labelled E. coli bacteria was measured using the commercial test kit Phagotest™ following the instructions of the manufacturer (PHAGO-Test®; ORPEGEN Pharma GmbH).
Proliferation assay
The assay was carried as follows: leucocytes (4 × 105 cells/well) were cultured in ninety-six-well flat-bottom tissue culture plates. To stimulate peripheral blood mononuclear cells, pokeweed mitogen (2·5 μg/ml), concanavalin A (5 μg/ml) and phytohaemagglutinin (10 μg/ml) were used. Incubation was performed at 37°C and 100 % relative humidity in a 5 % CO2 atmosphere. After 48 h of incubation, bromodeoxyuridine (60 μm) was added and cells were incubated under the same conditions for another 24 h. To measure bromodeoxyuridine incorporation, cells were fixed with ethanol (10 min on ice). Cells were washed and stained with a fluorescein isothiocyanate-conjugated antibody (mouse anti-bromodeoxyuridine; BD Pharmingen™) according to the manufacturer's instructions. The incorporation was detected using a FACSCalibur flow cytometer (Becton Dickinson).
Statistical analysis
Statistical analysis was conducted using the statistical program PASW 18.0 (IBM). Data distribution was tested using the Kolmogorov–Smirnov test with Lilliefors correction. For normally distributed data, a two-sided t test was performed. For non-normally distributed data, the Mann–Whitney test was applied. A P value of ≤ 0·05 was considered significant for all data. The experimental unit for the performance data (body weight, weight gain, feed intake and feed conversion) was the pen, and for the post-mortem data the individual.
Results
All animals showed an unimpaired general condition; diarrhoea did not occur. Initial body weight (8·23 (sd0·78) v. 8·30 (sd0·86) kg), final body weight (16·71 (sd1·51) v. 17·43 (sd1·30) kg), daily weight gain (0·30 (sd0·04) v. 0·33 (sd0·03) kg), daily feed intake (0·59 (sd0·10) v. 0·64 (sd0·10) kg) and feed conversion (1·96 (sd0·25) v. 1·95 (sd0·24)) were comparable in the control group and the fenugreek group.
pH and bacterial metabolites in the digesta
Compared with the control group, the pH was reduced in the fenugreek group in the caecum and colon (Table 2). A significant difference between the control animals and the fenugreek group was observed in the l-lactic acid concentrations in the small intestine (P< 0·05). The lactic acid concentration declined in the large-bowel digesta and was not different between the two groups. The total concentration of SCFA in the small intestine was very low and showed no feed-related differences. In the caecum, the levels of SCFA increased. However, absolute levels and the distribution of the acids were similar. In the colon digesta, butyric acid was higher in piglets fed the fenugreek diet compared with the control group (P< 0·05).
ND, not determined.
*Mean value was significantly different from that of the control group (P< 0·05).
† Data represent the average concentrations from three sampling sites (duodenum, jejunum and ileum), except the pH, that was measured in the proximal jejunum.
Bacterial cell numbers in the jejunal and caecal digesta
The bacterial cell numbers in the jejunum are shown in Table 3. Compared with the control diet, the counts of the Lactobacillus group were higher when feeding fenugreek (P= 0·018). A cell count increase was evident for L. johnsonii (P= 0·016). The jejunal concentration of the Escherichia group was significantly reduced by the addition of fenugreek (P= 0·048). Ingestion of fenugreek led also to increased cell numbers of clostridium cluster I (P= 0·048), while clostridium cluster XIV remained stable. In the caecum, L. reuteri and L. johnsonii were increased (P= 0·034 and 0·016) by the addition of fenugreek. The differences were only marginal for the other groups and species.
*Mean value was significantly different from that of the control group (P≤ 0·05).
† C. acetobutylicum, C. botulinum, C. butyrium, C. carnis, C. celatum, C. cellulovorans, C. chauvoei, C. cochlearium, C. fallax, C. haemolyticum, C. intestinale, C. peptidivorans, C. perfringens, C. putrefaciens, C. saccharobutylicum, C. septicum, C. sardiniensis, C. subterminale, C. tetani.
‡ C. aminovalericum, C. coccoides, C. herbivorans, C. indolis, C. nexile, C. oroticum, C. polysaccharolytium, C. scindens, C. xylanolyticum, C. xylanovora.
Blood counts, immune cell phenotyping and proliferation assays
Among the haematological parameters and the differential blood counts, no differences between the feeding groups were identified (data not shown). The piglets fed with fenugreek seed showed somehow altered composition of peripheral blood mononuclear cells (Table 4). The phenotypic analysis of circulating T cells showed a relative increase in CD8− γδ T cells, while no changes were observed concerning the portions of circulating CD8+γδ T cells. The percentages of the other T-cell populations measured during the animal study (CD4+ and CD8+) showed no clear alterations. NK cells (CD2+CD5−) also seemed to be unaffected. In the case of the antigen-presenting cells, a significant effect was observed in the outcome in that the percentage of major histocompatibility complex class II molecules (MHCII)-bearing CD5 cells was significantly reduced in the blood of the fenugreek group. Likewise, the median values of CD14+ cells (monocytes) and SWC3+ cells (all myeloid cells) were numerically lower in the group of fenugreek-treated piglets, while no changes were observed between the groups concerning the relative numbers of CD21+ cells (B cells) in the blood. The proliferation assays carried out with peripheral blood mononuclear cells from the different treated groups did not show any alterations. Phagocytosis also was not affected by the feeding of the piglets (data not shown).
*Median value was significantly different from that of the control group (P≤ 0·05). Mann–Whitney test was used for non-normally distributed data.
Discussion
Fenugreek seed has been previously described to have interesting properties affecting digestive function and the immune system of animals. We have demonstrated that fenugreek affected the intestinal microbiota as well as selected aspects of the immune function of piglets in the post-weaning period.
The administration of 1·5 g fenugreek seeds/kg diet led to a lower pH of the digesta with significant diet-dependent changes in the caecum and colon of piglets. The pH reduction in the digesta by fenugreek seeds can display either an increase in the number of lactate-producing bacteria or their relevant metabolic activity. Fenugreek seeds contain over 50 % carbohydrates in the DM(Reference Billaud and Adrian21). Soluble galactomannans seem to be the most interesting fraction, while the amount of insoluble fibre is small(Reference Madar and Shomer22). The hydrophilic galactomannans have a high water-holding capacity and the ability to form viscous gels(Reference Madar and Stark1), and seem to be a readily metabolisable substrate for the intestinal microbes, resulting in a higher production of organic acids. The concentrations of d-lactic acid were not affected by the seed. l-Lactic acid increased in the small intestine (P< 0·05), but was not influenced in the large intestine by fenugreek. This indicates that galactomannans are readily fermented in the upper gut by lactic acid bacteria and that lactic acid has been effectively metabolised in the large intestine by resident lactate-consuming bacteria. However, no increase in propionic acid and acetic acid was observed. These acids are the typical fermentation products of lactate fermentation(Reference Seeliger, Janssen and Schink23). Using a porcine large-intestinal simulation model, the fermentability of fenugreek gum, containing 26·2 % galactose and 31·4 % mannose, was also high and resulted in a high yield of acetate and butyrate. Lactic acid production was higher compared with flaxseed but considerably lower compared with the incubation of caecal microbes with β-glucans(Reference Lin, Gong and Wang9). This difference might either indicate a lack of coincidence of data from in vivo and in vitro models or it can also be explained by different amounts of test substances and compositional varieties of fenugreek seeds. In particular, the content of galactomannans may vary depending on various factors(Reference Thomas, Bandara and Lee3). In rats, high levels of gums from fenugreek seed increased the concentrations of caecal SCFA, particularly propionic and acetic acid, and increased the caecal weight and the amount of water in the faeces. The higher propionic acid formation was correlated with a significant decrease in caecal pH(Reference Evans, Hood and Oakenfull24). In piglets, fenugreek seed, included at a considerably lower dietary level, had no effect on the total concentration and the pattern of SCFA in the small intestine and in the caecal digesta. Compared with the control group, the SCFA profile was similar. However, higher n-butyrate was seen in the colon contents of the fenugreek group. Next, to a general change in carbohydrate fermentation patterns, this may also indicate that a higher lactate concentration was available for n-butyrate-producing bacteria, which belong to heterogeneous clostridium clusters(Reference Pryde, Duncan and Hold25). In the small intestine, a significantly increased l-lactate concentration as well as the strong numerical increases of lactobacilli, bifidobacteria and clostridium cluster I, which contains many butyrate-producing species, were observed. Thus, the increased n-butyrate formation may have been a result of increased lactic acid fermentation, which originated from the fermentation of soluble galactomannans in the upper gut. This finding is interesting due to the anticipated effects of butyrate as an energy-yielding substrate for the colonic epithelium in pigs(Reference Claus, Losel and Lacorn26, Reference Tsukahara, Iwasaki and Nakayama27) and prospectively for humans.
Indigestible carbohydrates may alter the composition of the intestinal microbiota in pigs. In the present study, the modified bacterial fermentation metabolites were accompanied by a marked change in the microbiota in the jejunal and caecal digesta. With the addition of fenugreek seeds, an increase in lactobacilli and some major representatives of this genus, including L. johnsonii and, as a trend, L. reuteri, was observed. These changes show that fenugreek seeds had apparently substrate effects in the intestine, although the concentration in the diet was relatively low. Diets containing mannans and galactomannans from different sources have been shown to affect the intestinal microbes in pigs. Piglets fed a diet with mannan oligosaccharides from yeast had higher faecal lactobacilli counts compared with the control animals(Reference White, Newman and Cromwell28). The increase in lactic acid-producing bacteria is interesting from the perspective of intestinal micro-ecology and due to the dietary impact on the occurrence of enterobacteria. A lower cell number of enterobacteria was observed in piglets after administration of fenugreek seeds. The change was not more than half a logarithm step, but was statistically significant. The addition of 0·2 % mannan oligosaccharides decreased enterobacteria concentrations in the jejunum digesta of piglets from 9·1 to 8·0 log/g(Reference Castillo, Martin-Orue and Taylor-Pickard29). The impact of galactomannans from guar gum, locust bean gum or carob tree seed on the intestinal microbiota in pigs appeared inconsistent(Reference Van Nevel, Decuypere and Dierick30). Total counts of bacteria were decreased by half a log unit in the proximal jejunum, while the number of E. coli increased in the stomach and in the jejunum. Increased ileal concentrations of total anaerobes, total aerobes, lactobacilli, enterobacteria and clostridia were determined in the ileum of piglets fed diets with very high concentrations (7 %) of guar gum(Reference Owusu-Asiedu, Patience and Laarveld31). From those findings, it can be concluded that the chemical composition of the indigestible carbohydrate fraction and the dietary inclusion level can have variable effects on the intestinal microbiota. Carbohydrates are considered to be most important, but other fractions of fenugreek seed, such as polyphenols, can have effects on the microbiota in pigs(Reference Hara, Orita and Hatano32). Regarding clostridia, a strong increase was observed for bacteria of clostridium cluster I in the small intestine, while clostridium cluster XIVa was not changed. Both clusters contain peptidolytic as well as saccharolytic species and therefore one cannot identify the exact net changes that occurred within both clusters. Proteolytic activities of the gut microbiota were not determined in the present study. However, given the increase in carbohydrate-fermenting lactic acid bacteria, it is conceivable that either saccharolytic clostridium species or lactate-fermenting clostridia gained an advantage.
The phenotyping of lymphocytes in the peripheral blood was characterised by a high variability of the data that is also known from other experiments with piglets(Reference Scharek, Altherr and Tolke33–Reference Boudry, Dehoux and Wavreille35). This variability makes careful interpretation of the observed diet-related differences mandatory. Fenugreek has been shown to affect immune variables in different animal models. The number of studies is scarce, but indicates some interesting effects. Galactomannans were able to affect phagocytosis in rat macrophages, and proliferation and IgM secretion in hybridoma cells(Reference Ramesh, Yamaki and Tsushida5). In mice, cellular/humoral response variables and phagocytic capacity of macrophages were affected in a dose-related manner(Reference Bin-Hafeez, Haque and Parvez6). In rats, fenugreek alleviated symptoms of experimental immunosuppression(Reference Ramadan, El-Beih and Abd El-Kareem8). CD8− γδ T cells were increased in piglets fed fenugreek compared with the control animals. Porcine γδ T cells have varying phenotypes and numerous functions, including a role in early responses against infections at epithelial surfaces, regulatory effects on different T-cell subsets and antigen-presenting cells, and are presumed to be crucial for both innate and specific immune responses in the young(Reference Takamatsu, Denyer and Stirling36–Reference Wen, Li and Zhang39). In the group of piglets fed with fenugreek seed, a significantly higher proportion of these so-called ‘non-classical T cells’(Reference Saalmüller, Hirt and Reddehase40, Reference Binns, Duncan and Powis41) was observed. In this group of piglets, CD8− γδ T cells outnumbered the populations of helper T cells as well as cytotoxic T cells, which was not the case in the control group. ‘Non-classical T cells’ have been reported to constitute approximately 15–25 % of lymphocytes in the peripheral blood of pigs(Reference Yang and Parkhouse42), which is in line with the present results. Unfortunately, until now, little is known about the physiology of CD8− γδ T cells. In contrast to CD8+γδ T cells, they do not respond to stimulation by mitogens including concanavalin A, phytohaemagglutinin and pokeweed mitogen, neither to foreign antigens(Reference Hammerberg and Schurig43, Reference Binns44). However, an extract from the plant Acanthospermum hispidum resulted in vitro in a proliferation of porcine CD8− γδ T cells based on an IL-2-dependent mechanism mediated by CD4 helper cells(Reference Summerfield and Saalmüller45). Both γδ T-cell subpopulations are high in the young piglet and decrease during the growth period. Therefore, they are considered to be of special importance for the development and maturation of the juvenile immune system. The expression of the CD8α molecule occurs after activation and is age-dependent, together with increasing MHCII expression(Reference Gerner, Kaser and Saalmüller37). The expansion of the CD8− γδ T subset can be explained by the direct effects of fenugreek on the gut-associated immune system, or it might be the consequence of the observed changes in the intestinal microbiota. This finding makes fenugreek interesting as an immune-modulating ingredient. However, the characterisation of functional significance requires further studies and the influence on the health status of the animals cannot yet be assessed. Moreover, the same group of piglets showed another deviation in the composition of blood leucocytes. The portion of MHCII+CD5− cells was significantly lower in the fenugreek-fed group compared with the control group. As CD5 is expressed on all porcine T cells, this CD5− MHCII-expressing population should be mainly B cells and monocytes. From the observation that the CD21+ population did not show any differences between the groups, we assume that the affected population is mainly composed of monocytes. This assumption is strengthened by the fact that the median values of CD14+ cells and SWC3a (CD172a and SIRPα+) cells were also decreased in the fenugreek group.
In conclusion, fenugreek had interesting effects in piglets, lowering the pH, and increasing the concentrations of lactic acid and lactobacilli in the digesta. Furthermore, the lower concentrations of enterobacteria indicate a change in the gut microbiota. The effects on the lymphocyte phenotypes in the peripheral blood of piglets have been noted. However, whether these findings affect colonisation resistance against invading pathogens and animal health has to be further evaluated.
Acknowledgements
This study was supported by Delacon Biotechnik GmbH, Steyregg, Austria. The contributions of each author are as follows: J. Z. contributed to the concept of the trial, supervision and writing of the manuscript; S. G. performed the practical work with the animal experiments and the laboratory work; L. T. contributed to the concept for the immunological methods and data evaluation; K. M. conducted the animal experiments, feed formulation and surveillance; A. M. contributed to the reviewing of the literature and manuscript; W. V. contributed to the microbiological work and the writing of the manuscript. The authors declare that there are no conflicts of interest.